ELIZABETH JENKINS: Open Payments
NPI 1346509767 · MCMINNVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 35 payments from 8 companies in 2025. Trend: 2023 $503 · 2024 $366 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $188 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $138 |
| Lilly USA, LLC | 5 | $91 |
| Novo Nordisk Inc | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 1 | $39 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, Kerendia, MOUNJARO, REXULTI, CAPLYTA, GVOKE HYPOPEN, Wegovy, Ozempic.
Industry payments across TN — which companies pay providers there.
